07-11-2024 |
PM |
|
MRNA |
Moderna, Inc. |
20,480 |
0.03 |
-1.91 |
-1.39 |
Moderna beats Q3 top and bottom line estimates [11/7/2024 6:42 AM] |
50.24 |
-1.57 (-3.03%) |
56.40 |
4.59 (8.86%) |
49.60 - 170.47 |
14,613,013 |
5,210,000 |
2,158,936 |
|
|
01-08-2024 |
PM |
|
MRNA |
Moderna, Inc. |
45,540 |
-3.33 |
-3.47 |
-3.62 |
Moderna GAAP EPS of -$3.33 beats by $0.02, revenue of $241M beats by $106.13M [8/1/2024 6:37 AM] |
94.02 |
-25.20 (-21.14%) |
100.00 |
-19.22 (-16.12%) |
62.55 - 170.47 |
16,580,658 |
2,350,000 |
1,015,607 |
|
|
02-05-2024 |
PM |
|
MRNA |
Moderna, Inc. |
42,650 |
-3.07 |
-3.59 |
0.19 |
Moderna GAAP EPS of -$3.07 beats by $0.50 [5/2/2024 6:36 AM] |
125.19 |
13.73 (12.32%) |
114.00 |
2.54 (2.28%) |
62.55 - 142.79 |
10,801,366 |
2,820,000 |
123,221 |
|
|
22-02-2024 |
PM |
|
MRNA |
Moderna, Inc. |
33,690 |
0.55 |
-0.82 |
3.61 |
Moderna Non-GAAP EPS of $0.55 beats by $1.54, revenue of $2.81B beats by $280M [2/22/2024 6:35 AM] |
99.53 |
11.94 (13.63%) |
91.00 |
3.41 (3.89%) |
62.55 - 163.24 |
10,139,126 |
4,160,000 |
284,088 |
|
|
02-11-2023 |
PM |
|
MRNA |
Moderna, Inc. |
28,910 |
-1.39 |
-1.98 |
2.53 |
ModernaEPS of -$9.53, revenue of $1.83B beats by $450M [11/2/2023 6:34 AM] |
71.23 |
-4.97 (-6.52%) |
71.23 |
0.0 (0.00%) |
62.55 - 217.25 |
15,104,693 |
4,440,000 |
10,050 |
|
|
03-08-2023 |
PM |
|
MRNA |
Moderna, Inc. |
43,430 |
-3.62 |
-3.84 |
5.24 |
Moderna beats Q2 top and bottom line estimates; updates FY23 outlook [8/3/2023 6:35 AM] |
109.95 |
-0.27 (-0.24%) |
109.95 |
0.0 (0.00%) |
108.26 - 217.25 |
5,438,016 |
3,690,000 |
28,751 |
|
|
04-05-2023 |
PM |
0:00 AM ET (May 4) |
MRNA |
Moderna, Inc. |
50,680 |
0.19 |
-1.77 |
8.58 |
Moderna GAAP EPS of $0.19 beats by $1.94, revenue of $1.9B beats by $730M [5/4/2023 6:33 AM] |
134.44 |
4.30 (3.30%) |
133.67 |
3.53 (2.71%) |
115.03 - 217.25 |
4,690,161 |
3,200,000 |
133,675 |
|
|
23-02-2023 |
PM |
0:00 AM ET (Feb 23) |
MRNA |
Moderna, Inc. |
64,000 |
3.61 |
4.66 |
11.29 |
Moderna GAAP EPS of $3.61 misses by $1.14, revenue of $5.1B beats by $80M [2/23/2023 7:04 AM] |
147.60 |
-10.57 (-6.68%) |
153.79 |
-4.38 (-2.77%) |
115.03 - 217.25 |
8,353,737 |
3,020,000 |
401,743 |
|
|
03-11-2022 |
PM |
7:15 AM ET (Nov 3) |
MRNA |
Moderna, Inc. |
60,490 |
2.53 |
3.04 |
7.70 |
Moderna GAAP EPS of $2.53 misses by $0.66, revenue of $3.36B misses by $170M [11/3/2022 7:04 AM] |
147.63 |
-0.99 (-0.67%) |
138.40 |
-10.22 (-6.88%) |
115.03 - 376.65 |
7,777,267 |
4,910,000 |
991,375 |
|
|
03-08-2022 |
PM |
7:10 AM ET (Aug 3) |
MRNA |
Moderna, Inc. |
65,040 |
5.24 |
4.50 |
6.46 |
Moderna Non-GAAP EPS of $5.24 beats by $0.75, revenue of $4.75B beats by $800M [8/3/2022 7:08 AM] |
186.11 |
25.30 (15.73%) |
167.74 |
6.93 (4.31%) |
115.61 - 497.49 |
12,830,251 |
3,270,000 |
223,400 |
|
|
04-05-2022 |
PM |
0:00 AM ET (May 4) |
MRNA |
Moderna |
54,170 |
8.58 |
5.18 |
0.00 |
Moderna GAAP EPS of $8.58 beats by $3.37, revenue of $6.1B beats by $1.67B [5/4/2022 6:53 AM] |
155.22 |
8.68 (5.92%) |
153.00 |
6.46 (4.41%) |
122.01 - 497.49 |
9,798,336 |
5,480,000 |
585,615 |
|
-
COVID-19 shot sales, performance of non-COVID portfolio in focus for Moderna's Q1 earnings [5/3/2022 3:48 PM]
-
Moderna GAAP EPS of $8.58 beats by $3.37, revenue of $6.1B beats by $1.67B [5/4/2022 6:53 AM]
-
Moderna gains after strong 1Q beat as COVID-19 vaccine sales exceed forecasts [5/4/2022 7:37 AM]
-
Moderna draws cautious views on Wall Street despite massive quarterly beat [5/4/2022 3:11 PM]
-
Moderna Earnings: What to Look For From MRNA [May-03-22 12:08PM]
-
UPDATE 1-Moderna keeps full-year COVID vaccine sales view unchanged [May-04-22 07:02AM]
-
Moderna Reports First Quarter 2022 Financial Results and Provides Business Updates [May-04-22 06:52AM]
-
Moderna Stock Jumps After Earnings Trounce Estimates [May-04-22 07:06AM]
-
Moderna keeps full-year COVID vaccine sales view unchanged [May-04-22 07:04AM]
-
Moderna sees higher COVID vaccine sales in second half of 2022 [May-04-22 07:04AM]
-
UPDATE 2-Moderna sees higher COVID vaccine sales in second half of 2022 [May-04-22 07:02AM]
-
Markets are primed for how Powell will respond to this key question on interest rates [May-04-22 07:48AM]
-
Moderna's stock soars 8% after beating revenue, earnings expectations for the quarter [May-04-22 07:33AM]
-
Moderna Stock Surges After Smashing Q1 Earnings Forecast, Affirming Vaccine Sales Forecast [May-04-22 07:33AM]
-
Bonds Drop, U.S. Futures Rise as Fed Hike Looms: Markets Wrap [May-04-22 07:31AM]
-
Moderna Surges After Obliterating First-Quarter Covid Vaccine Sales Projections [May-04-22 09:10AM]
-
Moderna Earnings: What Happened with MRNA [May-04-22 08:56AM]
-
Moderna Stock Gains After Smashing Q1 Earnings Forecast, Affirming Vaccine Sales Forecast [May-04-22 09:39AM]
-
Stocks Fluctuate, Bonds Fall Before Fed Decision: Markets Wrap [May-04-22 09:35AM]
-
Tech Leads Stock Losses as Yields Climb Before Fed: Markets Wrap [May-04-22 10:02AM]
-
Lyft stock tumbles, dragging down Uber stock with it [May-04-22 09:48AM]
-
Lyft, Match Group, Yum! Brands Fall Premarket; Starbucks, AMD, Airbnb Rise [May-04-22 03:45AM]
-
Moderna sees higher COVID vaccine sales later this year [May-04-22 07:04AM]
-
Why Moderna's Outlook Doesn't Inspire Hope For Covid Vaccine Sales [May-04-22 10:17AM]
-
Moderna CEO talks huge earnings beat, COVID-19 vaccine sales, new boosters [May-04-22 10:11AM]
-
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names [May-04-22 09:12AM]
-
Moderna (MRNA) Q1 Earnings and Revenues Top Estimates [May-04-22 08:25AM]
-
Several people who attended the White House Correspondents Dinner on Saturday have tested positive for COVID [May-04-22 10:41AM]
-
Moderna Stock Active After Smashing Q1 Earnings Forecast, Affirming Vaccine Sales Forecast [May-04-22 10:52AM]
-
This Number in Moderna's Q1 Results Is a Game-Changer [May-04-22 11:02AM]
-
Moderna CEO Says FDA Meeting Will Be Too Late to Switch Covid Strains for Fall Vaccine [May-04-22 11:32AM]
-
Stocks Halt Rebound Before Historic Fed Decision: Markets Wrap [May-04-22 11:26AM]
-
Moderna stock dips despite blowout quarterly earnings [May-04-22 11:42AM]
-
Moderna prepares to sell COVID-19 vaccine privately as US delays booster call [May-04-22 12:29PM]
-
Stock Market Falls Ahead Of Fed Announcement, Mixed Earnings, Slowing Service Sector [May-04-22 12:26PM]
-
Stocks Fluctuate Before Historic Fed Decision: Markets Wrap [May-04-22 12:21PM]
-
Several people who attended weekend White House correspondents dinner have since tested positive for COVID [May-04-22 10:41AM]
-
Is Moderna Stock A Buy On Its Big First-Quarter Covid Vaccine Number? [May-04-22 01:07PM]
-
Moderna targets autumn release for Omicron vaccine [May-04-22 12:02PM]
-
Stock Market Gains Ahead Of Fed Announcement; Oil And Utilities Sectors Shine [May-04-22 01:33PM]
-
Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies [May-04-22 11:39AM]
-
Stocks Rebound in Volatile Session Before Fed: Markets Wrap [May-04-22 01:47PM]
-
Stocks Drop, Bond Yields Climb After Fed Decision: Markets Wrap [May-04-22 02:35PM]
-
Pfizers got its eye on more than the COVID-19 market [May-04-22 02:28PM]
-
Stocks Rise, Bonds Fluctuate on Powells Remarks: Markets Wrap [May-04-22 02:47PM]
-
After soaring Covid-19 vaccine sales, Moderna lays out future plans [May-04-22 02:26PM]
-
Vaccine Makers Slump as Moderna, Pfizer Leave Full-Year Guidance Intact [May-04-22 02:25PM]
-
Stocks Rally as Powell Quells Fear of Bigger Hikes: Markets Wrap [May-04-22 02:56PM]
-
Why Moderna Stock Jumped Today [May-04-22 05:08PM]
|
24-02-2022 |
PM |
7:00 AM ET (Feb 24) |
MRNA |
Moderna, Inc. |
58,780 |
11.29 |
9.83 |
-0.69 |
Moderna GAAP EPS of $11.29 beats by $1.68, revenue of $7.21B beats by $480M, announces $3B buyback [2/24/2022 7:01 AM] |
156.15 |
20.42 (15.04%) |
0.0 |
0.0 (0.00%) |
117.34 - 497.49 |
16,179,047 |
10,666,895 |
0 |
|
-
How might a Sanofi-GSK COVID vaccine compete against mRNA shots? [2/23/2022 3:29 PM]
-
Moderna GAAP EPS of $11.29 beats by $1.68, revenue of $7.21B beats by $480M, announces $3B buyback [2/24/2022 7:01 AM]
-
Moderna unveils new booster; sees higher H2 sales amid endemic COVID-19 [2/24/2022 7:29 AM]
-
Moderna COVID vaccine recommended by EMA for children 6-11 years old [2/24/2022 11:41 AM]
-
Hot Stocks: MRNA, NKLA, LYV rally on quarterly results; BIRD rebounds from early slide [2/24/2022 11:51 AM]
-
Inflation Tops List of Investors' Concerns, Survey Says [Feb-23-22 01:45PM]
-
Why Moderna Stock Is Falling Today [Feb-23-22 01:40PM]
-
COVID-19 shot interval can be extended to 8 weeks for some -U.S. CDC [Feb-23-22 01:29PM]
-
Options Bears Target Moderna Stock Ahead of Earnings Report [Feb-23-22 01:15PM]
-
Moderna, Thermo Fisher Join Forces To Manufacture COVID-19 Vaccine, Other Drugs [Feb-23-22 12:58PM]
-
Moderna to Post Multi-Fold Jump in Q4 Earnings and Revenue [Feb-23-22 12:34PM]
-
Drug/Biotech Stocks' Q4 Earnings on Feb 24: MRNA, EBS & More [Feb-23-22 11:44AM]
-
Why Moderna Stock Is Down By 6% Today [Feb-23-22 11:34AM]
-
Moderna and Thermo Fisher Enter Long-Term Collaboration [Feb-23-22 10:49AM]
-
Sanofi-Glaxo Vaccine May Threaten Pfizer, Moderna in Covid-19 Booster Market [Feb-23-22 10:14AM]
-
No Buyers Ahead of Moderna Report [Feb-23-22 10:12AM]
-
Endo (ENDP) to Report Q4 Earnings: What's in the Cards? [Feb-23-22 10:11AM]
-
Moderna, Thermo Fisher partner to manufacture COVID vaccine, other drugs [Feb-23-22 08:57AM]
-
Moderna Earnings: What to Look For From MRNA [Feb-23-22 08:53AM]
-
Moderna and Thermo Fisher enter long-term agreement on large-scale manufacturing of COVID vaccine [Feb-23-22 08:36AM]
-
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration [Feb-23-22 08:00AM]
-
3 Ultra-Popular Stocks That Can Plummet Up to 65%, According to Wall Street [Feb-23-22 05:51AM]
-
Spain's Rovi raises guidance after 2021 profit jumped 151% [Feb-23-22 02:51AM]
-
Lowe's, Palo Alto, Virgin Galactic Rise Premarket; TJX Falls [Feb-23-22 02:49AM]
-
Spain's Rovi raises guidance after 2021 profit jumped 151% [Feb-23-22 02:44AM]
-
The Petri Dish: Moderna, Thermo become long-term partners; Karyopharm medical chief departs [Feb-24-22 05:39AM]
-
Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates [Feb-24-22 06:57AM]
-
Moderna raises COVID-19 vaccine sales forecast to $19 billion [Feb-24-22 07:10AM]
-
Moderna's COVID-19 shot generated $6.9 billion in sales in the fourth quarter [Feb-24-22 07:24AM]
-
Moderna Tops Q4 Earnings Forecast, Lifts 2022 Covid Vaccine Sales Guidance [Feb-24-22 07:18AM]
-
UPDATE 1-Moderna raises COVID-19 vaccine sales forecast to $19 billion [Feb-24-22 07:12AM]
-
Moderna Beats Earnings Estimates. The Stock Is Down. [Feb-24-22 07:28AM]
-
Moderna predicts boost to sales from COVID-19 turning endemic [Feb-24-22 07:10AM]
-
UPDATE 2-Moderna predicts boost to sales from COVID-19 turning endemic [Feb-24-22 07:12AM]
-
Moderna chairs advice to have more COVID-19 vaccine-style breakthroughs: Trust your crazy ideas [Feb-24-22 06:18AM]
-
Moderna Earnings: What Happened with MRNA [Feb-24-22 08:35AM]
-
Moderna Skids As $19 Billion Covid Vaccine Sales Outlook Lags Expectations [Feb-24-22 09:03AM]
-
Moderna Stock Leaps On Q4 Earnings Beat, 2022 Covid Vaccine Sales Boost [Feb-24-22 09:34AM]
-
Moderna Beats Earnings Estimates. The Stock Is Up. [Feb-24-22 09:23AM]
-
Stocks: Moderna rises on vaccine sales forecast, eBay slips on earnings outlook, Alibaba falls [Feb-24-22 09:57AM]
-
Moderna Stock Surges On Q4 Earnings Beat, 2022 Covid Vaccine Sales Boost [Feb-24-22 10:06AM]
-
Moderna is clawing back market share from Pfizer, analyst says [Feb-24-22 10:10AM]
-
Moderna Pops On Strong Covid Vaccine Sales, Though Offers Light Outlook [Feb-24-22 10:17AM]
-
Moderna expects COVID to become endemic in 2023, and Los Angeles County is latest to unveil plan to end face-mask mandates indoors [Feb-24-22 10:29AM]
-
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union [Feb-24-22 10:25AM]
-
Moderna says booster protection wanes after 9 months [Feb-24-22 10:09AM]
-
Moderna (MRNA) Beats Q4 Earnings and Revenue Estimates [Feb-24-22 08:45AM]
-
UPDATE 1-EMA backs Pfizer COVID booster for teens, Moderna shot for 6-11 year olds [Feb-24-22 10:54AM]
-
UPDATE 2-EMA backs Pfizer COVID booster for teens, Moderna shot for ages 6-11 [Feb-24-22 10:54AM]
-
COVID-19 vaccine global oversupply was preventable, Moderna CEO says [Feb-24-22 11:47AM]
-
Investors Cheer Lantheus' Wall Street-Beating FY22 Outlook [Feb-24-22 08:36AM]
-
Why Moderna Stock Is Surging Higher Today [Feb-24-22 12:32PM]
-
Stock Market Pares Losses After Russian Invasion; Nasdaq Escapes Most Of The Carnage [Feb-24-22 12:28PM]
-
Is Moderna Stock A Buy Or A Sell Amid Expectations For Endemic Covid? [Feb-24-22 12:54PM]
-
Moderna (MRNA) Q4 Earnings Top, COVID-19 Vaccine Brings $7B [Feb-24-22 11:33AM]
-
With War in Europe, Investors Flee Stocks, Seek Refuge in Gold, Bonds [Feb-24-22 01:52PM]
-
2 Nasdaq Stocks Rising Big in Thursday's Market Swoon [Feb-24-22 02:19PM]
-
Moderna firmly thinks another COVID-19 booster will be necessary this fall [Feb-24-22 03:08PM]
-
Moderna CEO Vows to Grow Vaccine Business as Competition Mounts [Feb-24-22 04:32PM]
-
Moderna Shares Soar on Earnings Beat, Upbeat Vaccine Sales Outlook [Feb-24-22 10:53AM]
|
04-11-2021 |
PM |
6:30 AM ET (Nov 4) |
MRNA |
Moderna, Inc. |
136,100 |
7.70 |
9.01 |
-0.59 |
Moderna EPS misses by $1.41, misses on revenue [11/4/2021 7:02 AM] |
284.02 |
-61.90 (-17.89%) |
283.83 |
-0.19 (-0.07%) |
68.92 - 497.49 |
28,678,388 |
6,410,000 |
5,605 |
|
-
Moderna EPS misses by $1.41, misses on revenue [11/4/2021 7:02 AM]
-
Moderna slips as Q3 financials lag expectations; trims full year forecast [11/4/2021 7:37 AM]
-
Hot Stocks: ROKU, MRNA, SKLZ decline on earnings; QCOM and GDDY rally [11/4/2021 8:47 AM]
-
Moderna drags COVID-19 vaccine developers lower after slashing outlook [11/4/2021 9:00 AM]
-
Why is Moderna stock down today? Earnings miss, lowered 2021 guidance [11/4/2021 3:56 PM]
-
U.S. administers 425.3 mln doses of COVID-19 vaccines - CDC [Nov-03-21 06:28PM]
-
COVID-19 vaccine has an incredibly positive benefit to risk ratio: Doctor [Nov-03-21 05:35PM]
-
What to expect in Moderna's Q3 earnings [Nov-03-21 02:34PM]
-
CDC recommends Pfizer COVID-19 vaccine for kids ages 5 to 11 [Nov-03-21 01:55PM]
-
Moderna Earnings: What to Look For From MRNA [Nov-03-21 11:44AM]
-
Drug, Biotech Stock Q3 Earnings on Nov 4: MRNA, REGN & More [Nov-03-21 11:04AM]
-
2 Reasons Moderna Can Continue Beating the Market [Nov-03-21 10:30AM]
-
How Bad Is This News for Moderna? [Nov-03-21 10:00AM]
-
Italy recommends Pfizer or Moderna booster for those who had J&J shot [Nov-03-21 09:59AM]
-
This News May Top Anything Else Moderna Says During Its Earnings Report [Nov-03-21 06:00AM]
-
Moderna Q3 Earnings to Swing From Year-Ago Losses; Revenue to Skyrocket [Nov-03-21 05:46AM]
-
Spanish Rovi's net profit doubles boosted by COVID vaccines [Nov-03-21 03:16AM]
-
Covid Vaccines for Children Are Here. What to Know. [Nov-03-21 12:01AM]
-
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2021 Earnings Call Transcript [Nov-03-21 12:00AM]
-
5 Large-Cap Stocks Expected to Increase Sales 313% to 1,304% by 2023 [Nov-04-21 05:51AM]
-
Is Moderna on Track to Win Authorization for Its Vaccine in Younger Kids? [Nov-04-21 06:05AM]
-
Could Moderna's mRNA Magic Revive Its Beaten-Down Biotech Partner? [Nov-04-21 06:00AM]
-
Moderna Reports Third Quarter Fiscal Year 2021 Financial Results and Provides Business Updates [Nov-04-21 07:00AM]
-
UPDATE 1-Moderna cuts full-year sales forecast for COVID-19 vaccine [Nov-04-21 07:09AM]
-
Moderna cuts full-year sales forecast for COVID-19 vaccine [Nov-04-21 07:06AM]
-
Moderna Stock Tumbles After Q3 Earnings Miss, 2021 COVID Vaccine Sales Cut [Nov-04-21 03:11AM]
-
Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumble [Nov-04-21 07:06AM]
-
Moderna's shares are down 10% after COVID-19 vaccine revenue comes in lower than expected [Nov-04-21 07:33AM]
-
Moderna, Qualcomm, Merck Active As Stocks Mixed In Fed Taper Wake: Jobless Claims In Focus [Nov-04-21 03:52AM]
-
Modernas Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market. [Nov-04-21 08:03AM]
-
Moderna Earnings: What Happened with MRNA [Nov-04-21 08:49AM]
-
Moderna Stock Plummets On Light Covid Vaccine Sales, Quarterly Profit [Nov-04-21 09:07AM]
-
Moderna misses in Q3, cuts forecast for COVID vaccine revenue [Nov-04-21 09:43AM]
-
Moderna (MRNA) Misses Q3 Earnings and Revenue Estimates [Nov-04-21 08:15AM]
-
Dow Jones Falls As Tesla Races To Record Highs; Moderna, Roku Dive On Earnings [Nov-04-21 10:18AM]
-
Market Check: Qualcomm soars consistently in early trading [Nov-04-21 10:36AM]
-
US STOCKS-Qualcomm, Big Tech lift S&P 500, Nasdaq to record highs [Nov-04-21 10:35AM]
-
Moderna scales back forecast for 2021 Covid-19 vaccine sales, citing delivery delays [Nov-04-21 10:09AM]
-
Moderna Crashes On Its Slashed 2021 Outlook Taking Vaccine Stocks With It [Nov-04-21 11:21AM]
-
Jobless Claims at New Post-Covid Lows, MRNA Misses by a Mile [Nov-04-21 10:28AM]
-
Moderna (MRNA) Q3 Earnings Miss, COVID-19 Vaccine Brings $5B [Nov-04-21 10:20AM]
-
Why Novavax Stock Is Sliding Today [Nov-04-21 11:57AM]
-
Why BioNTech Stock Is Falling Today [Nov-04-21 12:20PM]
-
Modernas manufacturing expertise is a moat for competition, analyst says [Nov-04-21 12:46PM]
-
US STOCKS-Big Tech, chipmakers power S&P 500, Nasdaq to record highs [Nov-04-21 12:42PM]
-
Weekly Jobless Claims Drop Significantly [Nov-04-21 10:51AM]
-
'Money and political power' changed the way we produce vaccines: Doctor [Nov-04-21 02:07PM]
-
Mid-Morning Market Update: Markets Mixed; Moderna Lowers Covid-19 Vaccine Sales Outlook [Nov-04-21 10:58AM]
-
Moderna Loses Top Spot on S&P 500 After Weakened Vaccine Outlook [Nov-04-21 01:31PM]
-
Why These 10 Stocks Are Moving on Thursday [Nov-04-21 03:05PM]
-
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus [Nov-04-21 12:07PM]
-
Mid-Day Market Update: Gold Rises 1.7%; Lightspeed Commerce Shares Plunge [Nov-04-21 12:38PM]
-
Why Moderna Stock Crashed Today [Nov-04-21 07:08PM]
-
Dow Jones Slips; Biden Vaccine Mandate Deadline Emerges, Moderna Plunges; Nvidia Stock Rockets [Nov-04-21 04:35PM]
-
Moderna Briefly Loses Top Spot on S&P 500 After Vaccine View [Nov-04-21 04:29PM]
-
RTP firm to coordinate study on Covid vaccines, autoimmune disease [Nov-04-21 04:05PM]
-
Modernas COVID-19 vaccine sales in the third quarter disappoint investors, and its stock takes a hit [Nov-04-21 03:56PM]
-
Mid-Afternoon Market Update: Nasdaq Jumps 150 Points; NeoPhotonics Shares Spike Higher [Nov-04-21 02:51PM]
|
05-08-2021 |
PM |
7:00 AM ET (Aug 5) |
MRNA |
Moderna, Inc. |
155,190 |
6.46 |
6.01 |
-0.31 |
Moderna EPS beats by $0.87, beats on revenue [8/5/2021 6:43 AM] |
416.35 |
-2.70 (-0.64%) |
411.00 |
-8.05 (-1.92%) |
54.21 - 443.99 |
23,708,732 |
18,140,000 |
1,257,698 |
|
-
Moderna EPS beats by $0.87, beats on revenue [8/5/2021 6:43 AM]
-
Moderna authorizes $1B in share repurchase program [8/5/2021 6:42 AM]
-
Moderna drops 3% despite Q1 beat; COVID-19 revenue of $4.2B [8/5/2021 7:16 AM]
-
Moderna's COVID vaccine shows 93% effectiveness six months after second dose [8/5/2021 9:15 AM]
-
France, Germany plan to offer booster shots, ignoring WHO plea - Reuters [8/5/2021 9:51 AM]
-
Why Moderna Stock Surged to a New All-Time High Today [Aug-04-21 05:35PM]
-
Moderna (MRNA) Option Traders Ready for Earnings Boost [Aug-04-21 03:07PM]
-
Sanofi to Buy mRNA Developer: ETFs in Focus [Aug-04-21 02:30PM]
-
Music events like Lollapalooza are not safe right now: Doctor [Aug-04-21 02:12PM]
-
Should the Lambda Variant Worry You? Not if Youre Vaccinated. [Aug-04-21 01:18PM]
-
Moderna, Wayfair, Beyond Meat Results: 3 Things to Watch [Aug-04-21 11:51AM]
-
WHO urges nations to prioritize the COVAX initiative [Aug-04-21 11:04AM]
-
Is a Surprise Coming for Moderna (MRNA) This Earnings Season? [Aug-04-21 11:03AM]
-
Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMN [Aug-04-21 10:39AM]
-
BioNTech, Moderna Soar As WHO Wants Nations To Hold Off Boosters [Aug-04-21 09:23AM]
-
Moderna Stock Jumps Before Earnings Report; Vaccines, FDA Move in Focus [Aug-04-21 09:01AM]
-
Indonesia Becomes Second in Asia to Hit 100,000 Covid Deaths [Aug-04-21 06:02AM]
-
3 Biotech Stocks That Could Make You Richer in August (and Beyond) [Aug-05-21 06:02AM]
-
Moderna says its COVID-19 shot remains 93% effective 4-6 months after second dose [Aug-05-21 06:31AM]
-
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates [Aug-05-21 06:29AM]
-
Moderna swings to big Q2 profit beat, as 199 million doses of COVID-19 vaccine were sold [Aug-05-21 06:49AM]
-
Moderna Stock Slips After Earnings Blowout on $4.2 Billion COVID Vaccine Sales [Aug-05-21 02:46AM]
-
Moderna Earnings Were Pretty Good. Thats Not Always Enough Following a 141% Rise. [Aug-05-21 07:03AM]
-
Moderna Earnings Crush Views; Covid Vaccine Maker Guides Higher, Sets Buyback [Aug-05-21 07:00AM]
-
Moderna says its COVID-19 shot 93% effective six months after second dose [Aug-05-21 06:31AM]
-
Moderna says its COVID-19 shot provides 93% immunity after six months [Aug-05-21 07:27AM]
-
UPDATE 1-Moderna says its COVID-19 shot 93% effective six months after second dose [Aug-05-21 07:17AM]
-
Are You Missing Out On A Sudden $85 Billion Biotech Stock Rally? [Aug-05-21 08:00AM]
-
WHO asks for halt to Covid-19 booster shots [Aug-05-21 08:50AM]
-
Moderna (MRNA) Q2 Earnings and Revenues Top Estimates [Aug-05-21 07:45AM]
-
UPDATE 2-Moderna says its COVID-19 shot 93% effective six months after second dose [Aug-05-21 07:17AM]
-
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Aug-05-21 08:50AM]
-
Moderna touts its COVID vaccine's endurance and earnings that beat expectations [Aug-05-21 10:19AM]
-
Delta variant is a 'wake up call', emergency physician says [Aug-05-21 08:50AM]
-
10 Best Biotech Stocks to Buy According to Alan Fraziers Frazier Healthcare Partners [Aug-05-21 10:50AM]
-
Moderna Stock Notches Yet Another Record As Earnings Obliterate Forecasts [Aug-05-21 10:48AM]
-
Global tally of COVID-19 cases top 200 million as U.S., Germany and France push back against WHO call on boosters [Aug-05-21 11:04AM]
-
Moderna beats on earnings as vaccination push continues [Aug-05-21 11:21AM]
-
Moderna CEO on importance of FDA approval: It's 'the credibility of our vaccine' [Aug-05-21 11:34AM]
-
UPDATE 3-Moderna says its COVID-19 shot maintains high efficacy through 6 months [Aug-05-21 09:27AM]
-
Global tally of COVID-19 cases tops 200 million as U.S., Germany and France push back against WHO call on boosters [Aug-05-21 11:04AM]
-
Moderna (MRNA) Q2 Earnings Top, COVID-19 Vaccine Brings $4.2B [Aug-05-21 10:27AM]
-
Moderna Stock, IBD 50 Stock To Watch, Notches New Record As Earnings Obliterate Forecasts [Aug-05-21 10:48AM]
-
Moderna INC (MRNA) Q2 2021 Earnings Call Transcript [Aug-05-21 01:01PM]
-
Moderna is buying back $1 billion of its stock after another bumper quarter [Aug-05-21 12:48PM]
-
Moderna CEO: Countries, not manufacturers, are responsible for WHO moratorium on boosters [Aug-05-21 01:09PM]
-
Doctor on booster shots: People shouldnt be so anxious to get another shot [Aug-05-21 01:47PM]
-
Is Moderna Stock A Buy After A $1 Billion Share Buyback Rattles Its Run? [Aug-05-21 01:58PM]
-
UPDATE 4-Moderna says COVID-19 shot maintains high efficacy through 6 months, sees eventual need for boosters [Aug-05-21 03:06PM]
-
Coronavirus vaccine: More people vaccinated is more important than boosters, doctor says [Aug-05-21 01:47PM]
-
Novavax data shows four-fold jump in antibody levels via booster shots [Aug-05-21 04:31PM]
-
Argentina handles Sputnik V delay by giving second jabs of other vaccines [Aug-05-21 04:25PM]
-
Moderna Earnings: What Happened with MRNA [Aug-05-21 04:22PM]
-
Why Moderna Stock Tested New Highs Today [Aug-05-21 11:16AM]
|
06-05-2021 |
PM |
7:00 AM ET (May 6) |
MRNA |
Moderna, Inc. |
69,530 |
2.84 |
2.04 |
-0.35 |
Moderna EPS beats by $0.74, misses on revenue [5/6/2021 7:04 AM] |
160.50 |
-2.34 (-1.44%) |
160.83 |
0.33 (0.21%) |
46.13 - 189.26 |
28,146,888 |
12,660,000 |
29,905 |
|
-
Moderna inks supply deal with Switzerland for booster COVID-19 vaccine [5/6/2021 7:08 AM]
-
Moderna posts first quarterly profit; revenue miss weighs on shares [5/6/2021 7:43 AM]
-
Weighing in on vaccine patent waivers, Alcon and Ultragenyx upgraded at Citi and more in analyst action [5/6/2021 9:42 AM]
-
Fauci eyes teens to reach herd immunity goal [5/6/2021 10:35 AM]
-
Germany's Merkel opposed to lifting IP protections on vaccines -- Bloomberg [5/6/2021 12:39 PM]
-
Dow Jones Futures: Market Rally Split On Vaccine Patent News, But Chevron, Goldman Lead 10 Stocks Flashing Buy Signals [May-05-21 08:47PM]
-
India Drugmaker Warning; Moderna Booster Effective: Virus Update [May-05-21 08:19PM]
-
Moderna Reports Excellent Results From Coronavirus Vaccine Booster Trial [May-05-21 08:05PM]
-
Why Moderna Stock Dropped Today [May-05-21 07:27PM]
-
Inside India's Serum Institute: The vaccine manufacturer at the heart of the world's COVID vaccine supply [May-05-21 07:00PM]
-
U.S. Backs Waiver of Intellectual Property Protection for Covid-19 Vaccines [May-05-21 06:37PM]
-
President Biden to back waiving IP protections for COVID vaccines [May-05-21 06:03PM]
-
Moderna Stock Dives As Biden Considers Waiving Covid Vaccine Patents [May-05-21 05:52PM]
-
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know [May-05-21 05:45PM]
-
Moderna releases new information on booster shots [May-05-21 05:22PM]
-
Moderna Says Its Covid-19 Booster Shots Show Promise Against Variants [May-05-21 04:50PM]
-
White House supports waiving IP protections for COVID vaccines [May-05-21 04:36PM]
-
UPDATE 1-Moderna booster increases antibodies against COVID-19 variants, early data shows [May-05-21 04:28PM]
-
Moderna says trial booster vaccine effective against COVID-19 variants [May-05-21 04:17PM]
-
Moderna Just Announced Positive Covid Vaccine Booster Data. What to Know. [May-05-21 04:06PM]
-
Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern [May-05-21 04:01PM]
-
Biden administration backs waiving IP protections for COVID vaccines [May-05-21 03:49PM]
-
CDCs projection of U.S. COVID-19 surge is a crystal ball: Doctor [May-05-21 02:06PM]
-
Moderna Earnings: What to Look for from MRNA [May-05-21 11:44AM]
-
Uber Outlook, Moderna Profit, Jobless Claims: 3 Things to Watch [May-05-21 11:41AM]
-
Investing in the Covid-19 vaccine companies? Heres the great divide in the group [May-05-21 11:14AM]
-
Moderna Reports Earnings on Thursday. Heres What to Expect. [May-05-21 09:12AM]
-
Should Pfizer and Moderna Be Worried About This New COVID Vaccine Study? [May-05-21 07:08AM]
-
Can This News Push Ocugen Ahead of Pfizer and Moderna? [May-05-21 06:30AM]
-
Why Moderna Could Triple Its COVID Vaccine Sales Next Year [May-05-21 05:52AM]
-
Dogecoin surges 55% as fans try to push it to $1 [May-05-21 03:43AM]
-
India Posts Record Cases, Deaths; Moderna Shots: Virus Update [May-06-21 02:32AM]
-
Biden Administration Supports Patent Waivers for Coronavirus Vaccine [May-05-21 09:44PM]
-
Dogecoin loses steam as other cryptos rally [May-06-21 04:44AM]
-
Moderna, Inc. to Host Earnings Call [May-06-21 06:15AM]
-
Vaxart Has 3 Advantages Over Pfizer and Moderna [May-06-21 06:00AM]
-
Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses [May-06-21 06:00AM]
-
Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates [May-06-21 07:03AM]
-
India Posts Record Cases, Deaths: Virus Update [May-06-21 07:19AM]
-
Moderna Misses Quarterly Revenue Forecast, Boosts Vaccine Sales Outlook [May-06-21 03:14AM]
-
Moderna reports $1.7 billion in COVID-19 vaccine sales, posts first profit ever [May-06-21 07:28AM]
-
Moderna lifts COVID-19 vaccine sales forecast to $19.2 billion [May-06-21 07:08AM]
-
Dow Jones Futures: Vaccine Makers Continue To Sell Off, But Chevron, Goldman Lead 10 Stocks Flashing Buy Signals [May-06-21 08:04AM]
-
U.S. Pushes Vaccine Waiver; Japans Emergency: Virus Update [May-06-21 08:25AM]
-
Moderna Earnings: What Happened with MRNA [May-06-21 08:16AM]
-
Moderna Crashes As Sales Lag Estimates In First Profitable Quarter [May-06-21 09:01AM]
-
U.S backs COVID-19 vaccine patent waiver [May-06-21 09:21AM]
-
US STOCKS-Futures flat after jobless claims data; drugmakers extend fall [May-06-21 09:09AM]
-
Moderna (MRNA) Beats Q1 Earnings Estimates [May-06-21 08:50AM]
-
Futures flat after jobless claims data; drugmakers extend fall [May-06-21 07:27AM]
-
Former Acting CDC Director on why it's 'really important' to pay attention to COVID-19 variants [May-05-21 02:06PM]
-
Wall St opens flat after jobless claims data; drugmakers extend fall [May-06-21 07:27AM]
-
Moderna Reports First Profitable Quarter. Patent Worries Are Slamming the Stock. [May-06-21 08:58AM]
-
U.S. Pushes Vaccine Waiver; 0lympic Shots: Virus Update [May-06-21 10:04AM]
-
U.S. backs COVID-19 vaccine patent waiver [May-06-21 09:21AM]
-
Global tally of COVID-19 cases tops 155 million as Biden supports waivers for vaccine patents [May-06-21 10:28AM]
-
US STOCKS-Nasdaq, S&P 500 slip as COVID-19 vaccine makers fall [May-06-21 10:20AM]
-
Moderna Posts Its First Profitable Quarter Ever in Q1 [May-06-21 10:35AM]
-
NYC Pitches Vaccine Tourism; India Breaks Records: Virus Update [May-06-21 10:50AM]
-
Moderna and Other Covid-19 Vaccine Stocks Are Sliding. The Reaction Might Be Overblown. [May-06-21 10:56AM]
-
Moderna Posts First Quarterly Profit, Revenue Disappoints [May-06-21 10:46AM]
-
Elizabeth Warren responds to Biden's backing of COVID-19 vaccine patent waivers: 'I'm delighted' [May-06-21 11:37AM]
-
US talk of waiving vaccine patents is merely symbolic: Experts [May-05-21 05:49PM]
-
Moderna falls, Peloton sees some recovery, and Kellogg rises. [May-06-21 11:42AM]
-
Moderna Weighs Down the Stock Market; Uber, Fastly Fall [May-06-21 11:59AM]
-
For just $25 billion, the U.S. could jump-start a project to quickly vaccinate the entire world against COVID [May-06-21 11:46AM]
-
Moderna's Bad News Just Got Worse But There's A Silver Lining [May-06-21 12:19PM]
-
Will Moderna (MRNA) Beat Estimates Again in Its Next Earnings Report? [May-06-21 12:10PM]
-
U.S. backing waiver of patent protection for vaccines is a complex issue: Doctor [May-06-21 01:54PM]
-
Vaccine Stocks Pare Deep Losses As Angela Merkel Opposes Waiving Patents [May-06-21 01:49PM]
-
Dow Jones Leads Stock Market Rebound; Moderna Stock Dives Despite Doing This [May-06-21 01:46PM]
-
Has Moderna (MRNA) Outpaced Other Medical Stocks This Year? [May-06-21 11:30AM]
-
Modernas first-ever profit and billion-dollar quarter is dampened by COVID-19 vaccine patent proposal [May-06-21 02:21PM]
-
Moderna Stock Is Facing Increasing Patent Pressure Is It A Buy Now? [May-06-21 02:34PM]
-
Column: Biden's plan to waive vaccine patents is good news, but not enough to beat the pandemic [May-06-21 05:49PM]
-
Moderna Turns First Profit, Boosted by Its Covid-19 Vaccine [May-06-21 05:34PM]
-
Let drugmakers keep their Covid vaccine profits [May-06-21 04:54PM]
-
India's COVID-19 cases soar with over 412,000 confirmed [May-06-21 04:16PM]
-
Dow Closes at Record High as Cyclicals Rally Ahead of April Jobs Report [May-06-21 12:06PM]
-
Moderna posts first-ever quarterly profit in Q1 [May-06-21 09:25AM]
-
Japan may approve AstraZeneca, Moderna vaccines as early as May 20 -Nikkei [May-06-21 08:41PM]
|
25-02-2021 |
PM |
7:00 AM ET (Feb 25) |
MRNA |
Moderna, Inc. |
59,420 |
-0.69 |
-0.25 |
-0.37 |
Moderna EPS misses by $0.28, beats on revenue [2/25/2021 7:03 AM] |
148.35 |
3.56 (2.46%) |
150.51 |
5.72 (3.95%) |
19.31 - 189.26 |
14,216,036 |
7,966,606 |
356,414 |
|
|
29-10-2020 |
PM |
7:00 AM ET (Oct 29) |
MRNA |
Moderna, Inc. |
27,890 |
-0.59 |
-0.43 |
-0.37 |
Moderna EPS misses by $0.21, beats on revenue [10/29/2020 7:02 AM] |
71.28 |
5.54 (8.43%) |
67.80 |
2.06 (3.13%) |
15.52 - 95.21 |
13,423,111 |
4,937,240 |
171,926 |
|
|
05-08-2020 |
PM |
7:00 AM ET (Aug 5) |
MRNA |
Moderna, Inc. |
27,510 |
-0.31 |
-0.36 |
-0.41 |
Moderna EPS beats by $0.03, beats on revenue [8/5/2020 7:13 AM] |
75.58 |
-2.88 (-3.67%) |
77.12 |
-1.34 (-1.71%) |
11.54 - 95.21 |
13,253,388 |
25,336,440 |
955,130 |
|
|